Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M708834200 on March 11, 2008

J. Biol. Chem., Vol. 283, Issue 19, 13269-13279, May 9, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/19/13269    most recent
M708834200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sarker, K. P.
Right arrow Articles by Bonni, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sarker, K. P.
Right arrow Articles by Bonni, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ING2 as a Novel Mediator of Transforming Growth Factor-β-dependent Responses in Epithelial Cells*Formula

Krishna P. Sarker{ddagger}1, Hiromi Kataoka{ddagger}12, Angela Chan{ddagger}1, Stuart J. Netherton{ddagger}3, Isabelle Pot{ddagger}3, Mai Anh Huynh§, Xiaolan Feng{ddagger}, Azad Bonni§, Karl Riabowol{ddagger}4, and Shirin Bonni{ddagger}5

From the Southern Alberta Cancer Research Institute, Departments of {ddagger}Biochemistry & Molecular Biology and Oncology, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada and the §Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115

Members of the ING (inhibitor of growth) family of chromatin modifying proteins (ING1-ING5) have emerged as critical regulators of gene expression and cellular responses, suggesting that the ING proteins may impinge on specific signal transduction pathways and their mediated effects. Here, we demonstrate a role for the protein ING2 in mediating responses by the transforming growth factor (TGF)-β-Smad signaling pathway. We show that ING2 promotes TGF-β-induced transcription. Both gain-of-function and RNA interference-mediated knockdown of endogenous ING2 reveal that ING2 couples TGF-β signals to the induction of transcription and cell cycle arrest. We also find that the Smad-interacting transcriptional modulator SnoN interacts with ING2 and promotes the assembly of a protein complex containing SnoN, ING2, and Smad2. Knockdown of endogenous SnoN blocks the ability of ING2 to promote TGF-β-dependent transcription, and conversely expression of SnoN augments ING2 enhancement of the TGF-β response. Collectively, our data suggest that ING2 collaborates with SnoN to mediate TGF-β-induced Smad-dependent transcription and cellular responses.


Received for publication, October 26, 2007 , and in revised form, February 4, 2008.

* This work was supported, in whole or in part, by National Institutes of Health Grant NS051255 (to A. B.) and by National Institutes of Health Training Grant GM077226 (to M. A. H.). This work was also supported by grants from the Alberta Cancer Board and the Canadian Institutes of Health Research (to S. B.) and the Harvard Medical School-Merck Sponsored Research Program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1-S9.

1 These authors contributed equally to this work.

2 Present address: Nagoya City University Graduate School of Medical Sciences, Dept. of Gastroenterology and Metabolism, 1-Kawasumi, Mizuhocho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.

3 Alberta Heritage Foundation for Medical Research Postdoctoral Fellow.

4 Alberta Heritage Foundation for Medical Research Scientist.

5 Alberta Heritage Foundation for Medical Research Scholar. To whom correspondence should be addressed: Southern Alberta Cancer Research Inst. and Dept. of Biochemistry & Molecular Biology, Faculty of Medicine, University of Calgary, 3330 Hospital Dr. N.W., Calgary, Alberta T2N 4N1, Canada. Tel.: 403-210-8587; Fax: 403-283-8727; E-mail: sbonni{at}ucalgary.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
Y. Ikeuchi, J. Stegmuller, S. Netherton, M. A. Huynh, M. Masu, D. Frank, S. Bonni, and A. Bonni
A SnoN-Ccd1 Pathway Promotes Axonal Morphogenesis in the Mammalian Brain
J. Neurosci., April 1, 2009; 29(13): 4312 - 4321.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement